Platelet glycoprotein VI: A novel marker for acute coronary syndrome

Seminars in Thrombosis and Hemostasis

Volumn 33, Issue 2, 2007, Pages 179-184

  Bigalke, Boris ^a   Langer, Harald ^a   Geisler, Tobias ^a   Lindemann, Stephan ^a   Gawaz, Meinrad ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acute coronary syndrome; Collagen; Glycoprotein (GP) VI; Platelets

Indexed keywords

CD36 ANTIGEN; CREATINE KINASE; GLYCOPROTEIN IB ALPHA; PADGEM PROTEIN; TROPONIN;

ACUTE CORONARY SYNDROME; ARTERY THROMBOSIS; ARTICLE; CELL SURFACE; DISEASE MARKER; FLOW CYTOMETRY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HIGH RISK PATIENT; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STABLE ANGINA PECTORIS;

BIOLOGICAL MARKERS; DISEASE SUSCEPTIBILITY; HUMANS; MYOCARDIAL ISCHEMIA; PLATELET MEMBRANE GLYCOPROTEINS; THROMBOSIS;

EID: 33947236476     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-969032     Document Type: Article

References (27)

1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8(11):1227-1234
2. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003;102(2):449-461
3. Kahn ML. Platelet-collagen responses: molecular basis and therapeutic promise. Semin Thromb Hemost 2004;30(4): 419-425
4. Moroi M, Jung SM. Platelet glycoprotein VI: its structure and function. Thromb Res 2004;114(4):221-233
5. Boylan B, Chen H, Rathore V, et al. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface. Blood 2004;104:1350-1355
6. Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 2004; 61(3):498-511
7. Lindemann S, Tolley ND, Eyre JR, et al. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J Biol Chem 2001;276(36):33947-33951
8. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001;154(3):485-490
9. Lindemann SW, Weyrich AS, Zimmerman GA. Signaling to translational control pathways: diversity in gene regulation in inflammatory and vascular cells. Trends Cardiovasc Med 2005;15(1):9-17
10. Penz S, Reininger AJ, Brandl R, et al. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 2005;19(8):898-909
11. Cosemans JM, Kuijpers MJ, Lecut C, et al. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis 2005;181(1):19-27
12. Cabeza N, Li Z, Schulz C, et al. Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 2004; 53(8):2117-2121
13. Samaha FF, Hibbard C, Sacks J, et al. Density of platelet collagen receptors glycoprotein VI and alpha2beta1 and prior myocardial infarction in human subjects, a pilot study. Med Sci Monit 2005;11(5):CR224-CR229
14. Clemetson KJ, McGregor JL, James E, et al. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest 1982;70(2):304-311
15. Sugiyama T, Okuma M, Ushikubi F, et al. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 1987;69(6):1712-1720
16. Gawaz M, Neumann FJ, Schomig A. Evaluation of platelet membrane glycoproteins in coronary artery disease: consequences for diagnosis and therapy. Circulation 1999;99(1): E1-E11
17. Fateh-Moghadam S, Bocksch W, Ruf A, et al. Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy. Circulation 2000; 102(8):890-897
18. Massberg S, Konrad I, Bultmann A, et al. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 2004;18(2): 397-399
19. Ikeda H, Takajo Y, Ichiki K, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995; 92(7):1693-1696
20. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115(12):3378-3384
21. Massberg S, Gawaz M, Gruner S, et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003;197(1):41-49
22. Ollikainen E, Mikkelsson J, Perola M, et al. Platelet membrane collagen receptor glycoprotein VI polymorphism is associated with coronary thrombosis and fatal myocardial infarction in middle-age men. Atherosclerosis 2004;176(1): 95-99
23. Croft SA, Samani NJ, Teare MD, et al. Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 2001;104:1459-1463
24. Joutsi-Korhonen L, Smethurst PA, Rankin A, et al. The low-frequency allele of the platelet collagen signalling receptor glycoprotein VI is associated with reduced functional responses and expression. Blood 2003;101:4372-4379
25. Furihata K, Nugent DJ, Kunicki TJ. Influence of platelet collagen receptor polymorphisms on risk for arterial thrombosis. Arch Pathol Lab Med 2002;126:305-309
26. Grüner S, Prostredna M, Aktas B, et al. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy. Circulation 2004;110:2946-2951
27. Bultmann A, Herdeg C, Li Z, et al. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo. Thromb Haemost 2006;95(5):763-766